179 related articles for article (PubMed ID: 29422542)
1. Protection of nigral dopaminergic neurons by AAV1 transduction with Rheb(S16H) against neurotoxic inflammation in vivo.
Kim S; Moon GJ; Oh YS; Park J; Shin WH; Jeong JY; Choi KS; Jin BK; Kholodilov N; Burke RE; Kim HJ; Ha CM; Lee SG; Kim SR
Exp Mol Med; 2018 Feb; 50(2):e440. PubMed ID: 29422542
[TBL] [Abstract][Full Text] [Related]
2. Neurotrophic interactions between neurons and astrocytes following AAV1-Rheb(S16H) transduction in the hippocampus in vivo.
Jeon MT; Moon GJ; Kim S; Choi M; Oh YS; Kim DW; Kim HJ; Lee KJ; Choe Y; Ha CM; Jang IS; Nakamura M; McLean C; Chung WS; Shin WH; Lee SG; Kim SR
Br J Pharmacol; 2020 Feb; 177(3):668-686. PubMed ID: 31658360
[TBL] [Abstract][Full Text] [Related]
3. Treatment with AAV1-Rheb(S16H) provides neuroprotection in a mouse model of photothrombosis-induced ischemic stroke.
Yoon D; Jeon MT; Dong Woon K; Kim SR
Neuroreport; 2020 Sep; 31(13):971-978. PubMed ID: 32694311
[TBL] [Abstract][Full Text] [Related]
4. Roles of Rheb(S16H) in substantia nigra pars compacta dopaminergic neurons
Jeon MT; Kim SR
Biomed Rep; 2015 Mar; 3(2):137-140. PubMed ID: 25798236
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Neuronal Rheb(S16H) for Hippocampal Protection in the Adult Brain.
Moon GJ; Shin M; Kim SR
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188096
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Potential of AAV1-Rheb(S16H) Transduction Against Alzheimer's Disease.
Moon GJ; Kim S; Jeon MT; Lee KJ; Jang IS; Nakamura M; Kim SR
J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31766645
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Potential of AAV1-Rheb(S16H) Transduction against Neurodegenerative Diseases.
Nam Y; Moon GJ; Kim SR
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802760
[TBL] [Abstract][Full Text] [Related]
8. Induction of GDNF and BDNF by hRheb(S16H) transduction of SNpc neurons: neuroprotective mechanisms of hRheb(S16H) in a model of Parkinson's disease.
Nam JH; Leem E; Jeon MT; Jeong KH; Park JW; Jung UJ; Kholodilov N; Burke RE; Jin BK; Kim SR
Mol Neurobiol; 2015 Apr; 51(2):487-99. PubMed ID: 24859383
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of neuronal astrocyte elevated gene-1 protects nigral dopaminergic neurons in vivo.
Leem E; Kim HJ; Choi M; Kim S; Oh YS; Lee KJ; Choe YS; Um JY; Shin WH; Jeong JY; Jin BK; Kim DW; McLean C; Fisher PB; Kholodilov N; Ahn KS; Lee JM; Jung UJ; Lee SG; Kim SR
Cell Death Dis; 2018 May; 9(5):449. PubMed ID: 29670079
[TBL] [Abstract][Full Text] [Related]
10. Induction of GDNF and GFRα-1 Following AAV1-Rheb(S16H) Administration in the Hippocampus
Yun D; Jeon MT; Kim HJ; Moon GJ; Lee S; Ha CM; Shin M; Kim SR
Exp Neurobiol; 2020 Apr; 29(2):164-175. PubMed ID: 32408406
[TBL] [Abstract][Full Text] [Related]
11. AAV transduction of dopamine neurons with constitutively active Rheb protects from neurodegeneration and mediates axon regrowth.
Kim SR; Kareva T; Yarygina O; Kholodilov N; Burke RE
Mol Ther; 2012 Feb; 20(2):275-86. PubMed ID: 22008911
[TBL] [Abstract][Full Text] [Related]
12. In vivo AAV1 transduction with hRheb(S16H) protects hippocampal neurons by BDNF production.
Jeon MT; Nam JH; Shin WH; Leem E; Jeong KH; Jung UJ; Bae YS; Jin YH; Kholodilov N; Burke RE; Lee SG; Jin BK; Kim SR
Mol Ther; 2015 Mar; 23(3):445-55. PubMed ID: 25502903
[TBL] [Abstract][Full Text] [Related]
13. Activation of CNTF/CNTFRα signaling pathway by hRheb(S16H) transduction of dopaminergic neurons in vivo.
Jeong KH; Nam JH; Jin BK; Kim SR
PLoS One; 2015; 10(3):e0121803. PubMed ID: 25799580
[TBL] [Abstract][Full Text] [Related]
14. Effects of Silibinin Against Prothrombin Kringle-2-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System In Vivo.
Leem E; Oh YS; Shin WH; Jin BK; Jeong JY; Shin M; Kim DW; Jang JH; Kim HJ; Ha CM; Jung UJ; Moon GJ; Kim SR
J Med Food; 2019 Mar; 22(3):277-285. PubMed ID: 30632945
[TBL] [Abstract][Full Text] [Related]
15. Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson's disease.
Jang H; Kim S; Lee JM; Oh YS; Park SM; Kim SR
Neuroreport; 2017 Mar; 28(5):242-249. PubMed ID: 28178069
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of prothrombin kringle-2-induced inflammation by minocycline protects dopaminergic neurons in the substantia nigra in vivo.
Nam JH; Leem E; Jeon MT; Kim YJ; Jung UJ; Choi MS; Maeng S; Jin BK; Kim SR
Neuroreport; 2014 May; 25(7):489-95. PubMed ID: 24488033
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic pathway reconstruction by Akt/Rheb-induced axon regeneration.
Kim SR; Chen X; Oo TF; Kareva T; Yarygina O; Wang C; During M; Kholodilov N; Burke RE
Ann Neurol; 2011 Jul; 70(1):110-20. PubMed ID: 21437936
[TBL] [Abstract][Full Text] [Related]
18. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
19. Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120).
Herzog CD; Brown L; Kruegel BR; Wilson A; Tansey MG; Gage FH; Johnson EM; Bartus RT
Neurobiol Dis; 2013 Oct; 58():38-48. PubMed ID: 23631873
[TBL] [Abstract][Full Text] [Related]
20. Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway.
Wu SY; Wang TF; Yu L; Jen CJ; Chuang JI; Wu FS; Wu CW; Kuo YM
Brain Behav Immun; 2011 Jan; 25(1):135-46. PubMed ID: 20851176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
